XALATAN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Xalatan, and what generic alternatives are available?
Xalatan is a drug marketed by Upjohn and is included in one NDA.
The generic ingredient in XALATAN is latanoprost. There are twenty drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the latanoprost profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Xalatan
A generic version of XALATAN was approved as latanoprost by AMRING PHARMS on March 22nd, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for XALATAN?
- What are the global sales for XALATAN?
- What is Average Wholesale Price for XALATAN?
Summary for XALATAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Clinical Trials: | 76 |
Patent Applications: | 6,239 |
Drug Prices: | Drug price information for XALATAN |
What excipients (inactive ingredients) are in XALATAN? | XALATAN excipients list |
DailyMed Link: | XALATAN at DailyMed |
Recent Clinical Trials for XALATAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Rigshospitalet, Denmark | Phase 4 |
Icahn School of Medicine at Mount Sinai | Phase 4 |
CHA University | Phase 4 |
US Patents and Regulatory Information for XALATAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upjohn | XALATAN | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 020597-001 | Jun 5, 1996 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for XALATAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Upjohn | XALATAN | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 020597-001 | Jun 5, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | XALATAN | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 020597-001 | Jun 5, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | XALATAN | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 020597-001 | Jun 5, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | XALATAN | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 020597-001 | Jun 5, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | XALATAN | latanoprost | SOLUTION/DROPS;OPHTHALMIC | 020597-001 | Jun 5, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for XALATAN
See the table below for patents covering XALATAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 101342 | ⤷ Sign Up | |
European Patent Office | 1224935 | ⤷ Sign Up | |
Japan | H08109132 | COMPOSITION FOR OPHTHALMOLOGY FOR LOCAL MEDICAL TREATMENT OFGLAUCOMA OR STENIA OF INTRAOCULAR TENSION CONTAINING PROSTAGLANDIN DERIVATIVE | ⤷ Sign Up |
European Patent Office | 1300150 | ⤷ Sign Up | |
Denmark | 200401645 | ⤷ Sign Up | |
Denmark | 176053 | ⤷ Sign Up | |
Denmark | 175842 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for XALATAN
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
3461484 | 122021000036 | Germany | ⤷ Sign Up | PRODUCT NAME: LATANOPROST, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, UND NETARSUDIL MESYLAT; REGISTRATION NO/DATE: EU/1/20/1502 20210107 |
0364417 | 97C0111 | Belgium | ⤷ Sign Up | PRODUCT NAME: LATANOPROSTUM; NAT. REGISTRATION NO/DATE: 277 IS 271 F 13 19970617; FIRST REGISTRATION: SE 12716 1996071 |
3461484 | 21C1024 | France | ⤷ Sign Up | PRODUCT NAME: ASSOCIATION DE NETARSUDIL OU L'UN DE SES SELS ET DE LATANOPROST; REGISTRATION NO/DATE: EU/1/20/1502 20210108 |
3461484 | 2021C/515 | Belgium | ⤷ Sign Up | PRODUCT NAME: ROCLANDA - LATANOPROST / NETARSUDIL; AUTHORISATION NUMBER AND DATE: EU/1/20/1502 20210108 |
0364417 | 61/1997 | Austria | ⤷ Sign Up | PRODUCT NAME: LATANOPROST UND SEINE THERAPEUTISCH AKTIVEN UND PHYSIOLOGISCH ANNEHMBAREN DERIVATE; NAT. REGISTRATION NO/DATE: 1-22019 19970627; FIRST REGISTRATION: SE 12716 19960718 |
0364417 | 97C0128 | France | ⤷ Sign Up | PRODUCT NAME: LATANOPROST; REGISTRATION NO/DATE IN FRANCE: NL 22549 DU 19970724; REGISTRATION NO/DATE AT EEC: 12716 DU 19960718 |
3461484 | C202130024 | Spain | ⤷ Sign Up | PRODUCT NAME: NETARSUDIL O UN ENANTIOMERO, DIASTEREIOISOMERO, SAL O SALVADO DEL MISMO EN COMBINACION CON LATANOPROST O UNA SAL DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/20/1502; DATE OF AUTHORISATION: 20210107; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/20/1502; DATE OF FIRST AUTHORISATION IN EEA: 20210107 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |